Emergent Biosolutions reported $72.9M in Gross Profit on Sales for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Gross Profit On Sales Change
Acadia Pharmaceuticals ACAD:US USD 128.58M 3.32M
Akebia Therapeutics AKBA:US USD 19.28M 96.99M
ALKERMES ALKS:US USD 201.73M 16.13M
Alnylam Pharmaceuticals ALNY:US USD 223.19M 39.18M
Amarin AMRN:US USD 65.94M 7.31M
Ani Pharmaceuticals ANIP:US USD 50.93M 12.37M
Biomarin Pharmaceutical BMRN:US USD 389.06M 21.62M
Chimerix CMRX:US USD 32.22M 31.78M
Exact Sciences EXAS:US USD 375.14M 1.9M
Glaxosmithkline GSK:US GBP 5.2B 244M
Intercept Pharmaceuticals ICPT:US USD 77.16M 5.72M
IONIS PHARMACEUT IONS:US USD 158.25M 29.21M
JAZZ PHA JAZZ:US USD 806.99M 1.68M
Merk MRK:US USD 10.47B 610M
Moderna Inc MRNA:US USD 2.26B 1.1B
Myriad Genetics MYGN:US USD 106M 23.6M
Nektar Therapeutics NKTR:US USD 18.65M 2.18M
Pacira Pharmaceuticals PCRX:US USD 116.79M 2M
Pfizer PFE:US USD 14.47B 2.08B
Ptc Therapeutics PTCT:US USD 203.12M 47.23M
Sarepta Therapeutics SRPT:US USD 190.32M 5.38M
Seattle Genetics SGEN:US USD 402.18M 10.78M
Teva Pharmaceutical Industries TEVA:US USD 1.71B 118M
United Therapeutics UTHR:US USD 478.8M 41.6M